Evidence map›Paper›PMID 42094927›Full record

ArticleJournal of pharmaceutical analysis2026

SMPD1-mediated sphingolipid metabolism dysregulation in predicting and preventing in-stent restenosis of coronary heart disease patients.

Weiyu Meng, Yuyang Sha, Ci-Ren Zhong-Ga, Hongxin Pan, Xiaobing Zhai, Pu Zhen, Henry H Y Tong, Edmundo Patricio Lopes Lao, Hongjia Zhang, Wenzhi Yang and 3 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Weiyu MengCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
Yuyang ShaCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
Ci-Ren Zhong-GaDepartment of Cardiology, Lhasa People's Hospital, Lhasa, Xizang Autonomous Region, 850000, China.
Hongxin PanCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
Xiaobing ZhaiCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
Pu ZhenDepartment of Cardiology, Lhasa People's Hospital, Lhasa, Xizang Autonomous Region, 850000, China.
Henry H Y TongCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.
Edmundo Patricio Lopes LaoDepartment of Cardiology, Macao Health Bureau, Macau SAR, 999078, China.
Hongjia ZhangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Wenzhi YangState Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Song CuiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Xiantao SongDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Kefeng LiCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SAR, 999078, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image 1.

Identifiers

PMID42094927
PMCPMC13141952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.